September 21, 2021

Amicus Brain participated in DemReCon 2019, Bengaluru

Amicus Brain participated in #DemReCon2019 at Bengaluru on 14 September 2019. The symposium was organized by Nightingales Medical Trust (NMT), a not-for-profit organization and India’s largest Dementia care provider.

Subroto Bagchi enthralls the panelists and audience alike at DemReCon 2019.

Subroto Bagchi, co-founder of Mindtree and author, was the chief guest. He gave a very impassioned speech to inaugurate the symposium that was well attended by geriatric physicians, psychologists, psychiatrists, scientists, researchers, and neurosurgeons. He emphasized on the need of empathy and sensitivity being major components of any dementia research.

At the symposium, NMT also launched its very own R&D division that promises to herald in a new era of dementia research in India. The symposium featured multiple speakers, who spoke about their research and work on dementia… Here are few highlights and facts derived from their individual presentations:

“Only 10% of dementia patients are even diagnosed in India.”

– Dr. Alladi Suvarna, Dept of Neurology, NIMHANS

“Hearing impairment is prevalent (more than 90%) in people with dementia (PwD). Hearing interventions will improve the delay of dementias. These interventions will not arrest dementias but will only delay their onset.”

– Prof. SP Goswami, Dept of Speech Pathology, AIISH, Mysuru

“The next BIG hike in dementia population will happen in developing nations and lower middle-income countries (LMIC), such as India (up to 189%)!”

– Dr. Anitha MS, Geriatric Psychiatrist, NMT

“India ranks third in the globe in dementia morbidity! In India, 1 out of every 16 households has someone with dementia. India is on the verge of becoming the country with the highest dementia morbidity very soon. Most Indian research on dementia is on animal models and on pharmacological impacts on animals, not on clinical research studies.”

– Prof. Sandeep Grover, Dept of Psychiatry, PGI, Chandigarh

“Our team has proved that Glutathione reduces in people with mild cognitive impairment (MCI) and reduces even further in PwDs. We used AI and machine learning to collate and compile data and inferences from multiple images and other data across our multi-center studies to arrive at this conclusion faster than usual.”

– Prof. Pravat Mandal, Scientist, National Brain Research Center, Gurugram

Apart from distinguished scientists, geriatric psychologists and psychiatrists, it was interesting to note that Chetan Mukundan, Director, Axxonet, addressed the gathering to collaborate more and more with healthtech and AI companies to accelerate their research work across medical and non-medical fields associated with dementia.

The day-long symposium was a successful stride in the right direction towards much needed dementia research and care in countries such as India.

Amicus Brain wishes all the researchers and organizations the very best in their future endeavors and hopes to partner and collaborate with them in any way we can. We look forward to participating in the next edition of this symposium.

Leave a Reply

Your email address will not be published. Required fields are marked *

Hey there!
Would you like to be notified when we publish new content?

You have successfully subscribed

There was an error while trying to send your request. Please try again.

Hopeful Trials & News will use the information you provide on this form to be in touch with you and to provide updates and marketing.